TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/13/25 20:20 | 2/11/25 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | M.d | 494 | 3.29 | 0 | 150 | 449 | 183 | D | ||||||||||||||
8/5/24 18:31 | 8/1/24 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | M.d | 169 | 2.81 | 0 | 60 | 102 | 119 | D | ||||||||||||||
1/12/24 20:06 | 1/8/24 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | M.d | 151 | 3.02 | 0 | 50 | 115 | 93 | D | ||||||||||||||
8/15/23 16:09 | 8/14/23 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | S | -632 | 30.89 | 0 | -20 | -22 | 73 | D | ||||||||||||||
8/9/23 18:15 | 8/8/23 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | M.d | 151 | 3.02 | 0 | 50 | 115 | 94 | D | ||||||||||||||
9/30/22 16:30 | 9/28/22 | CORT | Corcept Therapeutics Inc | DE | Health | Drug | Pharmaceutical Preparations | Hunt Hazel | CA | O | Chief Sc | M.d | 104 | 2.08 | 0 | 50 | 216 | 73 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |